Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 1475 entries
View as:

A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05981963 Org: User:
Start: 08/17/23 End: 10/22/23 Due: 10/22/24

Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT00395018 Org: User:
Start: 04/30/07 End: 03/31/11 Due: 03/31/12

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Phase: N/A Priority: Normal
NCT ID: NCT03500562 Org: User:
Start: 05/08/18 End: 03/29/19 Due: 03/29/20

A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT04237831 Org: User:
Start: 02/26/20 End: 07/16/21 Due: 07/16/22

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT05469737 Org: User:
Start: 12/14/22 End: 07/29/26 Due: 07/29/27

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT06073860 Org: User:
Start: 03/25/24 End: 12/21/27 Due: 12/21/28

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02581631 Org: User:
Start: 02/11/16 End: 02/07/22 Due: 02/07/23

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT01285609 Org: User:
Start: 01/16/11 End: 08/22/17 Due: 08/22/18

Comparative Tolerability of Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01450618 Org: User:
Start: 03/31/11 End: 10/31/12 Due: 10/31/13

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01858935 Org: User:
Start: 05/31/13 End: 02/28/14 Due: 02/28/15

Rollover Study of BMS-354825 in Patients With CML and Ph+ALL

Phase: N/A Priority: Normal
NCT ID: NCT01030718 Org: User:
Start: 01/31/06 End: 06/30/09 Due: 06/30/10

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Phase: N/A Priority: Normal
NCT ID: NCT02447341 Org: User:
Start: 03/31/15 End: 01/31/17 Due: 01/31/18

Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT00529178 Org: User:
Start: 12/31/02 End: 03/31/05 Due: 03/31/06

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02007655 Org: User:
Start: 09/01/13 End: 08/31/16 Due: 08/31/17

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

Phase: N/A Priority: Normal
NCT ID: NCT05445440 Org: User:
Start: 09/06/22 End: 11/23/22 Due: 11/23/23

Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01165216 Org: User:
Start: 09/30/10 End: 06/30/13 Due: 06/30/14

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT00393484 Org: User:
Start: 02/28/07 End: 09/30/13 Due: 09/30/14

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06877702 Org: User:
Start: 03/19/25 End: 08/29/25 Due: 08/29/26

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00484289 Org: User:
Start: 12/31/06 End: 12/31/10 Due: 12/31/11

A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05707390 Org: User:
Start: 02/20/23 End: 09/13/23 Due: 09/13/24

A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US

Phase: N/A Priority: Normal
NCT ID: NCT03732560 Org: User:
Start: 07/31/18 End: 03/25/21 Due: 03/25/22

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05963932 Org: User:
Start: 08/08/23 End: 10/17/23 Due: 10/17/24

A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03198182 Org: User:
Start: 06/28/17 End: 09/22/17 Due: 09/22/18

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Phase: N/A Priority: Normal
NCT ID: NCT01523171 Org: User:
Start: 04/30/12 End: 04/30/14 Due: 04/30/15

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Phase: N/A Priority: Normal
NCT ID: NCT00643201 Org: User:
Start: 07/31/08 End: 03/31/13 Due: 03/31/14